Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

FLJ31438 Inhibitors

FLJ31438 inhibitors are a class of small molecules or compounds that specifically interact with the FLJ31438 protein or its associated signaling pathways to modulate its activity. FLJ31438, also known as a gene of interest, may play a role in various cellular processes, often involving regulatory functions or signaling cascades, though the precise biological roles are still being elucidated. The inhibitors targeting FLJ31438 can be designed to either block its function directly by binding to active sites or allosteric sites or by interfering with its interactions with other proteins or cofactors. These inhibitors are usually studied through biochemical assays and cellular models to understand their effects on FLJ31438-associated pathways and molecular mechanisms. Understanding these inhibitors often involves detailed analyses of their binding affinities, structure-activity relationships (SAR), and effects on downstream cellular processes.

Chemically, FLJ31438 inhibitors may belong to various structural classes, such as heterocyclic compounds, aromatic rings, or complex scaffolds designed for optimal interaction with the FLJ31438 protein. These compounds are frequently evaluated for their specificity and potency through methods like high-throughput screening and computational docking studies. Characterization often includes techniques like X-ray crystallography or NMR spectroscopy to determine how the inhibitors bind to FLJ31438 at a molecular level. Further investigation into the biophysical properties, including solubility, stability, and permeability, allows for a comprehensive understanding of these inhibitors. Researchers studying FLJ31438 inhibitors focus on identifying key interactions that affect the protein's activity and exploring how modulation of FLJ31438 can impact broader cellular processes, such as gene expression, cell cycle regulation, or metabolic pathways.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A known kinase inhibitor that can reduce phosphorylation events required for protein activation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that can decrease downstream signaling, potentially affecting proteins regulated by this pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can affect protein synthesis and cellular growth pathways, altering protein function.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits eukaryotic protein synthesis by interfering with the translocation step in protein elongation.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

An ERK pathway inhibitor that can alter signal transduction affecting protein expression and activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAP kinase inhibitor that can modulate inflammatory responses potentially affecting protein regulation.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor that can prevent the degradation of regulatory proteins, altering protein homeostasis.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that can lead to accumulation of ubiquitinated proteins, affecting cellular regulation.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

A PI3K inhibitor that can block the phosphatidylinositol 3-kinase pathway, affecting numerous proteins.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, which can alter cellular responses such as apoptosis, thus affecting protein regulation.